Renalytix Receives Written Notification From Nasdaq On August 23, 2024 That Following The Presentation Of Its Operating And Financing Plan, The Co Has Been Granted An Extension Until October 25, 2024 To Regain Compliance With The Minimum Bid Price...

Renalytix於2024年8月23日收到納斯達克的書面通知，根據其營運和融資計劃的展示，該公司獲得了延期至2024年10月25日恢復最低買入價合規的批准。

Benzinga · 08/27 21:44

Renalytix Receives Written Notification From Nasdaq On August 23, 2024 That Following The Presentation Of Its Operating And Financing Plan, The Co Has Been Granted An Extension Until October 25, 2024 To Regain Compliance With The Minimum Bid Price Requirement And Other Applicable Nasdaq Listing Requirements

renalytix收到2024年8月23日的納斯達克書面通知，在其經營和融資計劃展示後，公司被授予延期至2024年10月25日以恢復最低買盤價格要求和其他適用的納斯達克上市要求

- SEC Filing

- SEC文件

譯文內容由第三人軟體翻譯。

以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。